Abstract
We investigated the efficacy of Shakuyaku-kanzo-to (TJ-68) in neuroleptic-induced hyperprolactinemia in 11 treated schizophrenic patients. The mean plasma prolactin level decreased significantly from 28.9 ± 14.5 ng/mL at baseline to 22.0 ± 15.2 ng/mL at 4 weeks. Potassium levels did not change significantly. Neither the exacerbation of psychosis nor other adverse effects occurred.
| Original language | English |
|---|---|
| Pages (from-to) | 341-342 |
| Number of pages | 2 |
| Journal | Psychiatry and clinical neurosciences |
| Volume | 50 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - Jan 1 1996 |
All Science Journal Classification (ASJC) codes
- Neuroscience(all)
- Neurology
- Clinical Neurology
- Psychiatry and Mental health
Fingerprint Dive into the research topics of 'Effectiveness of Shakuyaku-kanzo-to in neuroleptic-induced hyperprolactinemia: A preliminary report'. Together they form a unique fingerprint.
Cite this
Yamada, K., Kanba, S., Murata, T., Fukuzawa, M., Terashi, B., Yagi, G., & Asai, M. (1996). Effectiveness of Shakuyaku-kanzo-to in neuroleptic-induced hyperprolactinemia: A preliminary report. Psychiatry and clinical neurosciences, 50(6), 341-342. https://doi.org/10.1111/j.1440-1819.1996.tb00578.x